Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Tuesday, down -1.29% from the previous trading day, before settling in for the closing price of $8.50. Over the past 52 weeks, APLT has traded in a range of $1.79-$9.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 32.68%. With a float of $86.00 million, this company’s outstanding shares have now reached $114.85 million.
Let’s look at the performance matrix of the company that is accounted for 25 employees.
Applied Therapeutics Inc (APLT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 25.12%, while institutional ownership is 79.93%. The most recent insider transaction that took place on Aug 22 ’24, was worth 78,880. In this transaction Chief Financial Officer of this company sold 13,530 shares at a rate of $5.83, taking the stock ownership to the 277,911 shares. Before that another transaction happened on Aug 22 ’24, when Company’s Chief Medical Officer sold 22,681 for $5.83, making the entire transaction worth $132,230. This insider now owns 986,853 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.47 earnings per share (EPS), lower than consensus estimate (set at -0.26) by -0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 32.68% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 2.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 90.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 2.08 million, a positive change from its year-to-date volume of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 77.60%. Additionally, its Average True Range was 0.67.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 89.70%, which indicates a significant increase from 88.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 219.87% in the past 14 days, which was higher than the 105.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.18, while its 200-day Moving Average is $4.96. Nevertheless, the first resistance level for the watch stands at $8.65 in the near term. At $8.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.19. If the price goes on to break the first support level at $8.11, it is likely to go to the next support level at $7.83. Assuming the price breaks the second support level, the third support level stands at $7.57.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 963.59 million has total of 114,267K Shares Outstanding. Its annual sales at the moment are 9,990 K in contrast with the sum of -119,760 K annual income. Company’s last quarter sales were recorded 140 K and last quarter income was 2,900 K.
